POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to strengthen bones in older women
Disease control OngoingThis study is testing whether an investigational drug called AGA2118 can improve bone mineral density in postmenopausal women with low bone mass. Over 12 months, researchers will compare different doses of AGA2118 against a placebo to see which is most effective and safe. The goa…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Doctors test which bone drug works better for women at high fracture risk
Disease control OngoingThis study aims to compare how well two different FDA-approved osteoporosis medications work to strengthen bones in postmenopausal women at high risk of fractures. Researchers will follow 50 participants for 12 months, measuring changes in hip bone density. The goal is to help do…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC